Mar 25, 2021 / 02:30PM GMT
Nick Stone - AstraZeneca PLC - IR
Hello. Welcome, ladies and gentlemen, to today's Meet Astrazeneca Management Biopharmaceutical event. I'm Nick Stone, your moderator for today and a member of the Astrazeneca IR team. I'd like to welcome you to this opening session with Ruud Dobber, Executive Vice President of Biopharmaceuticals Business Unit; and Mene Pangalos, Executive Vice President of Biopharmaceuticals R&D. We also have several members of the Biopharmaceutical management team available as well.
This opening session will last for around 45 minutes. There'll be a short presentation, followed by Q&A. We will aim to finish around 3:15 to provide some time ahead of the first breakout session, which will start at 3:30. We'll then run a further breakout at 4:15, aiming to finish around 5:00. I hope you like the virtual setup and the potential to interact with Ruud and many members of the team.
As usual, the presentation materials are available on astrazeneca.com/investors, and we would encourage you to look here for all of the latest details. We've also sent the details and
AstraZeneca PLC BioPharmaceuticals Virtual Event - Opening and Q&A Session Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers